Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 3, 2017
Reporting Period: Second fiscal quarter ended June 30, 2017.
Context: This filing serves to announce the results of operations for the specified period via a press release (Exhibit 99.1), which is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the referenced press release (Exhibit 99.1) and are not present in this document text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the second quarter of 2017 were announced.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The company expressly disclaims any obligation to release publicly any updates or changes in expectations, events, conditions, or circumstances on which forward-looking statements are based.
- Legal Status: Information in this report is furnished pursuant to Item 2.02 and is not deemed "filed" under Section 18 of the Exchange Act. It shall not be incorporated by reference into any Securities Act or Exchange Act filings.
- Website Availability: The text notes that the press release is available on the company website, though the company reserves the right to discontinue availability at any time.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, EPS) by accessing the press release attached as Exhibit 99.1, as these numbers are absent from the 8-K cover text.
- Confirm the company's current liquidity position and debt levels through the referenced exhibit or subsequent 10-Q filing.
- Note the explicit disclaimer regarding future updates to forward-looking statements.
- Check the company website (www.therapeuticsmd.com) for the full text of the press release, acknowledging it may be removed at the company's discretion.